OptiNose, Inc. Common Stock
OPTN Real Time Price USDRecent trades of OPTN by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by OPTN's directors and management
Government lobbying spending instances
-
$10,000 Jul 20, 2021 Issue: Health Issues Budget/Appropriations
-
$30,000 Apr 19, 2021 Issue: Health Issues Budget/Appropriations
-
$20,000 Jan 19, 2021 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Delivery device and method Sep. 10, 2024
-
Patent Title: Intranasal administration Aug. 22, 2023
-
Patent Title: Intranasal administration Jul. 25, 2023
-
Patent Title: Delivery of gases to the nasal airway Jul. 04, 2023
-
Patent Title: Nasal delivery devices Mar. 14, 2023
-
Patent Title: Powder delivery devices Feb. 07, 2023
-
Patent Title: Nasal administration Jan. 17, 2023
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of OPTN in WallStreetBets Daily Discussion
Recent insights relating to OPTN
Recent picks made for OPTN stock on CNBC
ETFs with the largest estimated holdings in OPTN
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view OPTN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.